Humacyte, Inc. (HUMA)
1.35
-0.04
(-2.88%)
USD |
NASDAQ |
Jun 10, 16:00
1.19
-0.16
(-11.85%)
After-Hours: 20:00
Humacyte EPS Diluted (TTM) : -0.5747 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.5747 |
| December 31, 2025 | -0.2067 |
| September 30, 2025 | -0.2388 |
| June 30, 2025 | -0.4565 |
| March 31, 2025 | -0.6897 |
| December 31, 2024 | -1.263 |
| September 30, 2024 | -1.341 |
| June 30, 2024 | -1.264 |
| March 31, 2024 | -1.008 |
| December 31, 2023 | -1.071 |
| September 30, 2023 | -0.8651 |
| June 30, 2023 | -0.8592 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2847 |
| December 31, 2022 | -0.1192 |
| September 30, 2022 | 0.3235 |
| June 30, 2022 | -0.1492 |
| March 31, 2022 | -3.398 |
| December 31, 2021 | -6.662 |
| September 30, 2021 | -9.853 |
| June 30, 2021 | -9.136 |
| March 31, 2021 | -6.242 |
| December 31, 2020 | -2.786 |
| September 30, 2020 | -0.0017 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Altimmune, Inc. | -0.9376 |
| Protalix Biotherapeutics, Inc. | 0.1833 |
| Agenus, Inc. | 1.670 |
| Amgen, Inc. | 14.38 |
| BioCryst Pharmaceuticals, Inc. | -1.776 |